Pyxis Oncology, Inc. (PYXS) stock forecast and price target
Price $1.58 · data as of November 13, 2026
12-month price target
Average target$8.22
Upside / downside+420.4%
Analysts9
ConsensusStrong buy
Low $5.00Average $8.22High $19.00
Gold marker: average target · white marker: today’s price ($1.58)
Analyst ratings
Strong buy 1Buy 8Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.08 | +15.9% | $19440 |
| Next fiscal year ends December 31, 2027 | $-0.86 | +20.5% | $0 |
| Next quarter ends December 31, 2026 | $-0.21 | +27.6% | $19440 |
| Quarter after ends March 31, 2027 | $-0.21 | +42.6% | $0 |
Consensus of the analysts covering Pyxis Oncology, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.
Frequently asked questions
What is the Pyxis Oncology stock price target?
The average 12-month target from 9 analysts is $8.22, 420.4% above the current price of $1.58 Targets range from $5.00 to $19.00.
Is Pyxis Oncology a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 8 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Pyxis Oncology expected to earn?
Analysts expect EPS of $-1.08 for the fiscal year ending December 31, 2026 and $-0.86 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.